Tower Research Capital (TRC)’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $337K | Buy |
|
|||||
|
2025
Q1 | $27K | Sell |
|
|||||
|
2024
Q4 | $75.7K | Buy |
|
|||||
|
2024
Q3 | $3.59K | Sell |
|
|||||
|
2024
Q2 | $105K | Buy |
|
|||||
|
2024
Q1 | $15.3K | Sell |
|
|||||
|
2023
Q4 | $43.5K | Buy |
|
|||||
|
2023
Q3 | $12.6K | Buy |
|
|||||
|
2023
Q2 | $12.2K | Sell |
|
|||||
|
2023
Q1 | $13K | Sell |
|
|||||
|
2022
Q4 | $47K | Buy |
|
|||||
|
2022
Q3 | $29K | Buy |
|
|||||
|
2022
Q2 | $23K | Buy |
|
|||||
|
2022
Q1 | $7K | Sell |
|
|||||
|
2021
Q4 | $20K | Sell |
|
|||||
|
2021
Q3 | $44K | Sell |
|
|||||
|
2021
Q2 | $118K | Buy |
|
|||||
|
2021
Q1 | $70K | Sell |
|
|||||
|
2020
Q4 | $95K | Sell |
|
|||||
|
2020
Q3 | $436K | Buy |
|
|||||
|
2020
Q2 | $81K | Buy |
|
|||||
|
2020
Q1 | $10K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2K | Sell |
|
|||||
|
2019
Q2 | $8K | Sell |
|
|||||
|
2019
Q1 | $56K | Buy |
|
|||||
|
2018
Q4 | $38K | Buy |
|
|||||
|
2018
Q3 | $4K | Sell |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | $4K | Sell |
|
|||||
|
2017
Q4 | $30K | Buy |
|
|||||
|
2017
Q3 | $33K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $9K | Sell |
|
|||||
|
2016
Q2 | $14K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $10K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $21K | Buy |
|